Tue, May 17, 2011
Mon, May 16, 2011
Sun, May 15, 2011
[ Sun, May 15th 2011 ] - Market Wire
Teva to Acquire Taiyo
Fri, May 13, 2011
Thu, May 12, 2011
Wed, May 11, 2011
Tue, May 10, 2011
Mon, May 9, 2011
Sun, May 8, 2011
Sat, May 7, 2011
Fri, May 6, 2011
Thu, May 5, 2011
Wed, May 4, 2011
Tue, May 3, 2011
Mon, May 2, 2011
Fri, April 29, 2011
Thu, April 28, 2011
Wed, April 27, 2011
Tue, April 26, 2011
Mon, April 25, 2011
Fri, April 22, 2011
Thu, April 21, 2011
Wed, April 20, 2011
Tue, April 19, 2011

Arrowhead Research to Present at the 2011 MDB Capital Group Bright Lights Conference on May 10


//health-fitness.news-articles.net/content/2011/ .. al-group-bright-lights-conference-on-may-10.html
Published in Health and Fitness on Tuesday, May 3rd 2011 at 20:21 GMT by Market Wire   Print publication without navigation


PASADENA, Calif.--([ BUSINESS WIRE ])--Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, today announced that Dr. Christopher Anzalone, Chief Executive Officer, will present at the 2011 MDB Capital Group Bright Lights Conference at 2:00 p.m. ET on Tuesday, May 10, 2011. The conference will featureover 40of the most innovative companies with disruptive and market changing IP. The event is being held at the Le Parker Meridien Hotel in New York City.

Investors attending the conference are encouraged to schedule a one-on-one meeting at the conference with Arrowheada™s CEO Dr. Christopher Anzalone by contacting Brandi Floberg at [ arrowres@tpg-ir.com ] or 212-481-2050.

About Arrowhead Research Corporation

Arrowhead Research Corporation (NASDAQ: ARWR) is a nanomedicine company developing innovative therapeutic products at the interface of biology and nanoengineering to cure disease and improve human health. Arrowhead addresses its target markets through focused subsidiaries, which include: Calando Pharmaceuticals, a leader in delivering small RNAs for gene silencing; Ablaris Therapeutics, an anti-obesity therapeutics company; and Nanotope, a regenerative medicine company. For more information please visit [ http://www.arrowheadresearch.com ].


Publication Contributing Sources